Neuroky

Neuroky is a neuro-AI company dedicated to the development of digital biomarkers for the early detection and monitoring of neurological and psychiatric conditions. The company's platform utilizes advanced artificial intelligence to analyze behavioral and physiological data, such as speech patterns and motor functions, to identify early signs of brain health decline. Neuroky focuses on indications including Alzheimer's disease, Parkinson's disease, and depression, aiming to provide objective and non-invasive tools for clinical decision-making. By facilitating remote monitoring and early diagnosis, the company seeks to transform the management of neurodegenerative disorders and improve patient quality of life.